1980
DOI: 10.1016/s0021-9258(19)85758-7
|View full text |Cite
|
Sign up to set email alerts
|

Sarcoma growth factor from mouse sarcoma virus-transformed cells. Purification by binding and elution from epidermal growth factor receptor-rich cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
1
0

Year Published

1981
1981
1998
1998

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 73 publications
(3 citation statements)
references
References 16 publications
2
1
0
Order By: Relevance
“…The results reported here indicate that exposure Of NRK cells to biologically active concentrations of TGF-/3 leads to a change in EGF/TGF-a cell surface receptors. In confirmation of previous results (39), we find that EGF/TGF-a receptors in NRK cells that are mitogenically responsive to TGF-/3 exhibit a complex ligand binding pattern (Fig. 4).…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…The results reported here indicate that exposure Of NRK cells to biologically active concentrations of TGF-/3 leads to a change in EGF/TGF-a cell surface receptors. In confirmation of previous results (39), we find that EGF/TGF-a receptors in NRK cells that are mitogenically responsive to TGF-/3 exhibit a complex ligand binding pattern (Fig. 4).…”
Section: Discussionsupporting
confidence: 92%
“…5 and 6). The sharing of a common receptor species by EGF and TGF-a has been documented in other cell types as well (1,7,39,40). The decreased affinity labeling of this receptor species in TGF-/3-treated NRK cells as compared with untreated cells is consistent with it being the target for TGF-/3 regulation of TGF-a and EGF binding.…”
Section: Discussionsupporting
confidence: 56%
“…It can be activated extracellularly by one of several ligands that share a common EGF structural motif characterized by three loops imposed by intramolecular disulfide bonds (1). Six ligands have been well characterized to date: epidermal growth factor (EGF) (2), transforming growth factor alpha (TGFR) (3), amphiregulin (AR) (4), heparin-binding EGF-like growth factor (HB-EGF) (5), betacellulin (BTC) (6), and epiregulin (7). AR, HB-EGF, and BTC possess extended N-terminal tails that, in the case of AR and HB-EGF, include heparin binding motifs.…”
mentioning
confidence: 99%